I-Corps: Translation Potential of Modulation of Mitochondrial Function and its Implication — NSF Award to University of Illinois a
The broader impact of this I-Corps project is the development of a drug to mitigate/recover from long-term neurotoxic side effects of radiation. This technology holds promise in managing radiation injuries during cancer treatment. By targeting mitochondrial dysfunction and promoting the growth of neural progenitor cell
| Award title | I-Corps: Translation Potential of Modulation of Mitochondrial Function and its Implication |
|---|---|
| Award ID | 2434542 |
| Awardee | University of Illinois at Chicago |
| City | CHICAGO |
| State | IL |
| Amount obligated | $50,000 |
| Principal investigator | Aryamitra Banerjee |
| Program | I-Corps |
| Start date | 09/01/2024 |
| Abstract | The broader impact of this I-Corps project is the development of a drug to mitigate/recover from long-term neurotoxic side effects of radiation. This technology holds promise in managing radiation injuries during cancer treatment. By targeting mitochondrial dysfunction and promoting the growth of neural progenitor cells, the approach aims to address radiation induced injuries during surface cancer therapy. This technology may also help mitigate/recover from long-term neurotoxic side effects of r |
| Source | NSF Awards |
$799/mo
Try NSFGrants →